Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Everolimus × Breast × Clear all

Phase

Status

Sponsor Class

OTHER 73 INDUSTRY 44 NETWORK 3 UNKNOWN 1 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Paclitaxel 7 Epirubicin 7 Capecitabine 7 pyrotinib 5 Docetaxel 5 Carboplatin 5 Vinorelbine 4 Fulvestrant 4 Cyclophosphamide 4 exemestane 3 anlotinib 3 Radiotherapy 3 Radiation Dose Hypofractionation 3 Etoposide 3 pirarubicin 2 palbociclib 2 apatinib 2 Standard of Care 2 Neoadjuvant Therapy 2 Letrozole 2 Albumin-Bound Paclitaxel 2 toripalimab 1 titanium silicide 1 nimotuzumab 1 neratinib 1 lobaplatin 1 liposomal doxorubicin 1 icaritin 1 eribulin 1 Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02313051 2014-12-09

MIRACLE

ChineseAMS

Phase 2 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡